Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008–2011.
The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Candidemia is common and associated with high morbidity and mortality; changes in population-based incidence rates have not been reported. METHODS: We conducted active, population-based surveillance in metropolitan Atlanta, Georgia, and Baltimore City/County, Maryland (combined population 5.2 million), during 2008-2011. We calculated candidemia incidence and antifungal drug resistance compared with prior surveillance (Atlanta, 1992-1993; Baltimore, 1998-2000). RESULTS: We identified 2675 cases of candidemia with 2329 isolates during 3 years of surveillance. Mean annual crude incidence per 100 000 person-years was 13.3 in Atlanta and 26.2 in Baltimore. Rates were highest among adults aged ≥65 years (Atlanta, 59.1; Baltimore, 72.4) and infants (aged <1 year; Atlanta, 34.3; Baltimore, 46.2). In both locations compared with prior surveillance, adjusted incidence significantly declined for infants of both black and white race (Atlanta: black risk ratio [RR], 0.26 [95% confidence interval {CI}, .17-.38]; white RR: 0.19 [95% CI, .12-.29]; Baltimore: black RR, 0.38 [95% CI, .22-.64]; white RR: 0.51 [95% CI: .29-.90]). Prevalence of fluconazole resistance (7%) was unchanged compared with prior surveillance; 32 (1%) isolates were echinocandin-resistant, and 9 (8 Candida glabrata) were multidrug resistant to both fluconazole and an echinocandin. CONCLUSIONS: We describe marked shifts in candidemia epidemiology over the past 2 decades. Adults aged ≥65 years replaced infants as the highest incidence group; adjusted incidence has declined significantly in infants. Use of antifungal prophylaxis, improvements in infection control, or changes in catheter insertion practices may be contributing to these declines. Further surveillance for antifungal resistance and efforts to determine effective prevention strategies are needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“All-cause in-hospital mortality of candidemia has been reported as high as 36% in the US.27,51,52”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [51]
In the citing paper
“Candidemia is one of the most common health care–associated BSIs in the United States, with all-cause in-hospital mortality of up to 30%.”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [6]
In the citing paper
“In population-based surveillance performed in the metropolitan areas of Atlanta, Georgia, and Baltimore, Maryland, candidemia incidence (primarily among adults) increased 10%–40% from the early 1990s and the late 2000s, which was followed by more recent reports of decreases in these areas (6,28–30).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [6]
In the citing paper
“This contrasts with data from the early 1990s, when infants had the highest incidence (6), followed by substantial decreases by the late 2000s (26,28).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [6]
In the citing paper
“The previously reported racial disparity in candidemia persisted in this surveillance period (6), with a 2.3 times higher incidence among blacks than among nonblacks.”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [6]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198 · cited 1×
“%) met criteria for sepsis [19].”
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 1×
“Candida species are among the most common causes of BSIs and are associated with high morbidity and mortality, as well as increases in hospital cost and length of stay [1–5].”
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU
Pronovost, P., Needham, D., Berenholtz, S., Sinopoli, D., Chu, H., Cosgrove, S., Sexton, B., Hyzy, R., Welsh, R., Roth, G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061115 · Cited by 4,387 · cited 2×
“…dramatic declines in some central line– associated BSIs (CLABSIs), such as those associated with Staphylococcus aureus , following adherence to established central line insertion practices; however, similar dramatic declines have been less evident for CLABSIs due to Candida species [20, 24, 34–36].”
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Whiting, P., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. M., & Kleijnen, J. (2003) · BMC Medical Research Methodology · doi:10.1186/1471-2288-3-25 · Cited by 3,592
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · cited 1×
“shown to decrease risk of disease [21, 25–29].”
Boyle, J. P., Thompson, T. J., Gregg, E. W., Barker, L. E., & Williamson, D. F. (2010) · Population Health Metrics · doi:10.1186/1478-7954-8-29 · Cited by 1,309 · cited 1×
“Increases in common risk factors such as diabetes [30], ICU admissions [31, 32], or numbers of patients receiving immunosuppressive therapies [33] may have resulted in increases in the overall pool of patients at high risk for candidemia.”
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140 · cited 2×
“0 %) between centres [2, 14, 18, 31] possibly because of lack of standardized criteria.”
Research works printed but not linked: 2
- 1992, Chest, 10, 1644
- 2011, MMWR. Morbidity and mortality weekly report, 60, 243
Cited by
Items 301–400 of 411
Invasive yeast infections in the intensive care unit of a tertiary care centre in South India
Kindo, A. J., Ramaraj, V., Alagiri, S., & Vijayaraman, R. S. (2024) · Journal of The Academy of Clinical Microbiologists · doi:10.4103/jacm.jacm_29_16 · Cited by 4
“Approximately 7% and 1% of all the candidaemia isolates tested at CDC are found to be resistant to Fluconazole and Echinocandins, respectively.[15] Among our study isolates, all the Candida species were found to be sensitive to Anidulafungin and Micafungin.”
BackgroundUpdated estimated incidence and prevalence of serious fungal infections in Trinidad and Tobago
Edwards, R. J., Boyce, G., Alastruey‐Izquierdo, A., & Denning, D. W. (2021) · IJID Regions · doi:10.1016/j.ijregi.2021.09.007 · Cited by 4
Sobel, J. D. (2015) · Springer eBooks · doi:10.1007/978-3-319-13090-3_8 · Cited by 4
Adolescent eating disorder with catheter‐related bloodstream infection
Tamura, A., Minami, K., Tsuda, Y., Mizumoto, K., & Suzuki, H. (2020) · Pediatrics International · doi:10.1111/ped.14511 · Cited by 4
Frecuencia y factores de riesgo para fungemia por especies de Candida
Henao, S. B., Gómez, J. R. M., Restrepo, C. A. A., Rincón, C. I. G., Arboleda-Arias, N., Pérez-Giraldo, P. A., Ospina-Chaparro, L., Ruiz-Giraldo, S., & Hidrón-Botero, A. (2023) · Acta Médica Colombiana · doi:10.36104/amc.2024.2734 · Cited by 3
Choi, M. H., Kim, D., Yoon, J. G., & Jeong, S. H. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.107998 · Cited by 3
Evolution in the Management of Invasive Fungal Infections in Liver Transplant Recipients
Verma, A., Weigel, K., Dexter, S. Y. K., & Dhawan, A. (2018) · OBM Transplantation · doi:10.21926/obm.transplant.1802009 · Cited by 3
Anaya, E. U., & Neumann, A. K. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2019.11.1432 · Cited by 3
The structure of the oropharyngeal genus Candida fungi community in HIVinfected patients
Voropaev, A. D., Yekaterinchev, D. A., Nesvizhsky, Y. V., Zverev, V. V., Afanasiev, S. S., Volchkova, E. V., Afanasiev, M. S., Budanova, E. V., Boshjan, R. E., Likhanskaya, E. I., et al. (2020) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-tso-1450 · Cited by 3
Vora, M., Girija, A. S. S., Gunasekaran, S., & Jayaseelan, V. P. (2024) · Journal of pharmacopuncture · doi:10.3831/kpi.2024.27.2.91 · Cited by 3
“The overexpression of multidrug transporter genes in C. albicans is one of the resistance mechanisms to azole antifungals [7].”
BackgroundAlkan, S., Günal, Ö., KILIÇ, S. S., Köksal, E., & Tahmaz, A. (2020) · Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi · Cited by 3
Sultan, S. (2016) · InTech eBooks · doi:10.5772/60789 · Cited by 3
Pinhati, H. M. S. (2015) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2015.10.t.19942 · Cited by 3
Candida albicans ribosome : structure, function, and inhibition
Bruchlen, D. (2016) · theses.fr (ABES) · doi:10.70675/862d474az0392z478bza236zfef48870b895 · Cited by 3
“C. albicans does not have a primary resistance to azoles but its occurrence is not rare after treatment, and several studies have shown an increase of these resistances (Cleveland et al., 2012; Lockhart et al., 2012).”
Ткаченко, П. В., Tkachenko, O. V., Netosova, K., Borisov, O. V., & Zhuravel, I. O. (2017) · News of pharmacy · doi:10.24959/nphj.17.2158 · Cited by 2
Faustova, M. O., Dobrovolskyi, V., Лобань, Г. А., Bereza, Y., Kotelnikova, A., & Dobrovolskyi, O. V. (2024) · Frontiers in Oral Health · doi:10.3389/froh.2024.1446045 · Cited by 2
Probiotics in Invasive Candidiasis
Colombo, J., & Arena, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802189-7.00048-4 · Cited by 2
Horn, K. G. V., Sneed, D., & Goldstein, E. J. C. (2018) · Clinical Microbiology and Infectious Diseases · doi:10.15761/cmid.1000133 · Cited by 2
Emmanuela, I. N., Anthony, C. M., Ugwuijem, E. E., & Onwumere, S. I. (2019) · African Journal of Microbiology Research · doi:10.5897/ajmr2018.9027 · Cited by 2
“Some Candida spp., such as C. glabrata and C. krusei have been shown to acquire decreased susceptibility to fluconazole (Cleveland et al., 2012; Pfaller et al., 2015).”
BackgroundCandida, the Opportunistic Human Pathogen
Shahabudin, S., & Azmi, N. S. (2020) · Materials science forum · doi:10.4028/www.scientific.net/msf.981.309 · Cited by 2
Fungal infections—Background to specific fungal species
Sokóvić, M., & Λιάρας, Κ. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815824-1.00002-0 · Cited by 2
Santos, J. G. D., Pacheco, L. D. S., Barros, N. B. D., & Alves, E. R. D. S. (2022) · Brazilian Journal of Development · doi:10.34117/bjdv8n5-527 · Cited by 2
An Overview of Candidemia Patients in Tertiary Hospital, Surabaya, Indonesia
Pratiwi, C. A., Airlangga, P. S., & Endraswari, P. D. (2022) · International Journal of Research Publications · doi:10.47119/ijrp10011111020224019 · Cited by 2
Jahan, T., Farhana, A., & Nargis, S. (2023) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20231055 · Cited by 2
Sabadin, C. E. S., da Matta, D. A., Hoppe, L., Fernandes, F. A. V., Melo, A. S. D. A., Rigo, L., & Barbosa, D. A. (2024) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2024ao0138 · Cited by 2
“(13,14) This research is of extreme clinical importance because invasive fungi have emerged as a leading cause of disease in patients with compromised immune systems.”
BackgroundBaxa, J. A. V. D. (2014) · Clinical Microbiology Open Access · doi:10.4172/2327-5073.1000154 · Cited by 2
Hennessey, J. P., & Sardesai, N. Y. (2014) · Springer eBooks · doi:10.1007/978-3-662-45024-6_9 · Cited by 2
Ababneh, M., Abu-Bdair, O. A., Mhaidat, N. M., & Almomani, B. A. (2017) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.8634 · Cited by 2
de Brito, D. Z., Cassemiro, N. S., de Souza, J. M. E., Damasceno‐Júnior, G. A., Oliveira, R. J., Carollo, C. A., & Chang, M. R. (2021) · Planta Medica International Open · doi:10.1055/a-1494-1117 · Cited by 2
Case Commentary: Extending our therapeutic range against multidrug-resistant Candida
Adelman, M. W., & Andes, D. R. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00847-24 · Cited by 2
Experimental combination therapy against azole-based multidrug resistant Candida auris
Toepfer, S. (2023) · Otago University Research Archive (University of Otago) · Cited by 2
Gautam, S., Das, S., Singh, P. K., Rai, G., Jain, C. M., Saha, R., Singh, N. P., Gomber, S., Eltayeb, R., & Dar, S. A. (2023) · Diagnostics · doi:10.3390/diagnostics13091638 · Cited by 1
Polymer-Lipid Hybrid Nanoparticles for Enhanced Gentamicin Efficacy Against Drug-Resistant Bacteria
Yassin, A. E. B., Alsuwayyid, F., Alkhathran, L., Alrouisan, S., Alotaibi, G. M., Alyaqub, M., Alsalman, W., Alzahrani, R. R., Farh, I., Halwani, M., et al. (2025) · Nanotechnology Science and Applications · doi:10.2147/nsa.s548941 · Cited by 1
Development of Machine Learning Models to Predict Candidemia in Hospitalized Adult Patients
Hashimoto, K., MATSUMOTO, K., & Murotani, K. (2025) · The Kurume Medical Journal · doi:10.2739/kurumemedj.ms721234017 · Cited by 1
Uddin, Z., Tahsin, S., Valíčková, K., Long, T., Macedo, L. F. D., Popencuk, G., Zhao, Y., & Healey, K. R. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03874-25 · Cited by 1
“Alarmingly, between 8% and 13% of C. glabrata strains in North America are currently considered fluconazole-resistant (5, 10).”
CHANGING PATTERN OF DRUG RESISTANCE IN CANDIDA –A REVIEW
P. Sneka, D. M. K., Krishnan, M., P, H. K., & Janakiraman, R. (2023) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2023.14.02.233 · Cited by 1
Candidosen als Folge einer Chemotherapie: Hefepilze auf Haut und Schleimhaut
Nenoff, P. (2014) · hautnah dermatologie · doi:10.1007/s15012-014-1762-z · Cited by 1
Antimicrobial activity and immunological side effects of different antibiotics.
Dorić, M., Abram, M., & Rukavina, T. (1993) · PubMed · Cited by 1
Zhou, H., & Fuller, J. (2018) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi.3.1.09 · Cited by 1
Sadek, M., Poirel, L., & Nordmann, P. (2019) · Pediatric Dimensions · doi:10.15761/pd.1000197 · Cited by 1
Development of methods for population-based surveillance of influenza
Merk, H. (2013) · Figshare · Cited by 1
Aldarvis, J. D. G. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.23.2014.tde-28032014-193715 · Cited by 1
Cabral, D. B. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2014.tde-08012015-104423 · Cited by 1
Screening for Antibacterial and Antifungal Compounds in Bersama Abyssinica Fresen
Ong’era, T. N. (2016) · Kenyatta University Institutional Repository (Kenyatta University) · Cited by 1
Thomaz, D. Y. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-13022019-163819 · Cited by 1
Estudio de la resistencia a los antifúngicos en hongos patógenos humanos
Rivero-Menéndez, O. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Makarovaite, V. (2019) · Kent Academic Repository (University of Kent) · Cited by 1
Currie, A. (2021) · Kent Academic Repository (University of Kent) · doi:10.22024/unikent/01.02.86837 · Cited by 1
Advances in Fungal Infection Research: From Novel Diagnostics to Innovative Therapeutics
Rodrigues, C. F., & Černáková, L. (2025) · Journal of Fungi · doi:10.3390/jof11100693 · Cited by 1
“The importance of systematic surveillance in healthcare settings cannot be over-stated [30,31].”
Martí-Carrizosa, M., & de Microbiologia, U. A. D. B. D. D. G. I. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Forte, T. M. (2020) · e_Buah · Cited by 1
Oud, L. (2016) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2484w
“Our findings are in agreement with studies in the US that did not focus on ICU patients, showing large decreases in 30-day mortality in two metropolitan areas [23] and at a single-center setting [42].”
BackgroundResultInfluentialDomán, M. (2016) · University of Debrecen Electronic Archive (University of Debrecen)
Total Parenteral Nutrition Changes Species Distribution in Patients with Fungemia
Pate, A. J., Baltazar, G. A., Jung, Y.-S., Vernaleo, J. R., & Chendrasekhar, A. (2014) · The American Surgeon · doi:10.1177/000313481408001102
Frühzeitig und konsequent behandeln: Candidosen in der Chemotherapie
Nenoff, P. (2013) · Uro-News · doi:10.1007/s00092-013-0260-7
“glabrata), die multiresistent gegen Fluconazol und Echinocandine waren [6].”
BackgroundPuig‐Asensio, M. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Souza, M. D., & Neufeld, P. M. (2016) · Vigilância Sanitária em Debate · doi:10.22239/2317-269x.00668
“Urina 20 (45,4) 15 (34,0) 2 (4,6) 2 (4,6) 3 (6,8) 1 (2,3) 1 (2,3) 44 (44,0)”
Resource utilisation and the evolution of antifungal resistance in Candida species
Duxbury, S. J. N. (2017) · Figshare
Prevention of Invasive Candidiasis in Premature Neonates: Administering Fluconazole or Not?
Donà, D., Luise, D., Baraldi, E., & Trafojer, U. (2018) · Current Fungal Infection Reports · doi:10.1007/s12281-018-0312-2
The impact of lemongrass, oregano, and thyme essential oils on Candida albicans’ virulence factors
Eddins, J. M. (2021) · Access Microbiology · doi:10.1099/acmi.cc2021.po0018
“limited available treatment options (Cleveland et al., 2012).”
BackgroundSajith, M. (2018) · International Journal of Pharmacognosy & Chinese Medicine · doi:10.23880/ipcm-16000128
NASİBOĞLU, B., Dokuzeylül, B., Alkan, F. A., Barutçu, Ü. B., & Or, M. E. (2018) · Journal of Advances in VetBio Science and Techniques · doi:10.31797/vetbio.482028
Incorporating Filastatin into medical plastics to minimize nosocomial fungal infections
Lipsky, Z. W., & Pierce, Z. (2016) · Digital WPI
Scharmann, U. (2019) · DuEPublico (University of Duisburg-Essen) · doi:10.17185/duepublico/47899
Bacterial carbohydrates trigger Candida albicans virulence
Burch, J. M. (2018) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/yx8b-xp18
An Investigation into Clinically Relevant Determinants of Azole Resistance in Candida albicans
Nishimoto, A. T. (2019) · doi:10.21007/etd.cghs.2019.0486
“In particular, mortality associated with Candida bloodstream infections remains high, and proper treatment of the infection increases hospitalization costs and length of stay considerably (59, 68, 182).”
BackgroundKhezri, M. H., Zaini, F., Kordbache, P., Ghahri, M., Ardi, P., Mahmoudi, S., Ahmadikia, K., & Rafat, Z. (2019) · doi:10.36811/ijbm.2019.110016
“By identifying the sensitivity of different species of blood-derived candida to common antifungal drugs such as azoles, polyenes and echinocandins, the mortality rate of candidemia can be reduced [5].”
BackgroundThe prescribing practices of echinocandins in adult patients in a private hospital
de Grey, A. D. N. J. (2018) · Boloka Institutional Repository (North-west University)
Fraser, M. (2019) · UWE Research Repository (UWE Bristol)
Sule, H., Kumurya, A. S., & Ibrahim, A. (2020) · UMYU Journal of Microbiology Research (UJMR) · doi:10.47430/ujmr.2051.006
John, C. N. (2019) · University of the Western Cape Electronic Theses and Dissertations Repository (University of the Western Cape)
Incorporating Filastatin into medical plastics to minimize nosocomial fungal infections
Pierce, B. J. (2016) · Digital WPI
Perlin, D. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_29
Sphingolipids modulate echinocandin susceptibility in opportunistic fungi
Healey, K. R., & KATIYAR, S. K. (2013) · iDEA - Drexel University Institutional Repository · doi:10.17918/00000971
Frühzeitig und konsequent behandeln: Candidosen in der Chemotherapie
Nenoff, P. (2013) · Im Focus Onkologie · doi:10.1007/s15015-013-0536-5
“glabrata), die multiresistent gegen Fluconazol und Echinocandine waren [27].”
BackgroundChoice of initial antifungal therapy in critically Ill patients
Saj, S. M., Vasanthan, K., Madhavan, S., & Vengadakrishnan, K. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns5.11000
“Furthermore, the mortality rates associated with these infections range from 30%-81%.[2,3,4,5]”
BackgroundPál, S. E. (2022) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.11334
Mutations in ERG 11 Gene Among FluconazolePreprint
Sheena, M. S., & Singh, R. (2024) · Preprints.org · doi:10.20944/preprints202401.0367.v1
Investigation translationnelle de la chromatine
Kennani, S. E. (2019) · theses.fr (ABES) · doi:10.70675/5ebfee7fz60b0z4cdazb1a1z505f772dc195
Invasive Fungal Disease in an Intensive Care Unit of Tertiary Care Hospital of Bangladesh
Rahman, A. K. M. F., Kafi, S. A., & Pammi, F. J. (2024) · Saudi Journal of Medical and Pharmaceutical Sciences · doi:10.36348/sjmps.2024.v10i08.008
“In the developed world, C. albicans has a low incidence of fluconazole resistance, approximately 0.5–2% [28].”
BackgroundInfluentialSelivanova, L. V., Balalaeva, M. A., Dymova, O. V., Chernova, E. V., Лукина, М. В., Krucenko, A. A., Petrenko, D. А., Dmitrieva, S. S., & Eremenko, A. A. (2024) · Messenger of Anesthesiology and Resuscitation · doi:10.24884/2078-5658-2024-21-4-85-91
Rassan, M. A., Ewaisha, R., Zeitoun, H., & Shehat, M. G. (2025) · Letters in Applied Microbiology · doi:10.1093/lambio/ovaf055
Enongene, R. B., Toh-Boyo, G. M., Ndosiri, B. N., Nfor, E. N., Ofiong, O. E., & Louis, H. (2025) · Computational Chemistry · doi:10.4236/cc.2025.134004
Clinical Aspects of Fungal Infections
Loreto, É. S., Tondolo, J. S. M., & Zanette, R. A. (2025) · Fungal biology · doi:10.1007/978-3-032-06014-3_6
Megri, Y., Arastehfar, A. A., Boekhout, T., Daneshnia, F., Hörtnagl, C., Sartori, B., Hafez, A., Pan, W., Lass‐Flörl, C., & Hamrioui, B. (2020) · Figshare · doi:10.6084/m9.figshare.12096960
Meyahnwi, D., Siraw, B., & Reingold, A. L. (2022) · Figshare · doi:10.6084/m9.figshare.21547405
He, Z., Huo, X., & Piao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26558750
He, Z., Huo, X., & Piao, J. (2023) · Figshare · doi:10.6084/m9.figshare.26558753
Deep mutational scanning to study the role of epistasis in antifungal resistance.
Alexander, E. M. M. (2023) · Corpus Université Laval (Université Laval)
Efeito antifúngico e potencial mecanismo de ação do peptídeo PmUreβ em espécies de Candida
Perin, A. P. A. (2023) · Lume (Universidade Federal do Rio Grande do Sul)
Rare yeast and resistance mechanisms
Hansen, A. P. (2019) · Digital Library of the University of Innsbruck (University of Innsbruck)
ROSSELLI DEL TURCO, E. (2014) · Electronic Theses and Dissertations Repository (University of Pisa)
Candida blóðsýkingar á Íslandi 2009-2016
1992, R. R. T. (2017) · Skemman
Identificazione ed antimicogramma rapido di lieviti da emocolture positive.
Vecchione, A. (2017) · Electronic Theses and Dissertations Repository (University of Pisa)
de Souza, A. C. R. L. A. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Murillo-Rojas, Á. F., Ng-Araya, R. A., Lozada-Alvarado, S., Jaikel-Víquez, D., & Valverde-Vindas, A. (2026) · Acta Microbiologica Hellenica · doi:10.3390/amh71010002
“Furthermore, a trend toward increased resistance among isolates has been reported [4,5] due to self-medication and the indiscriminate use of treatments, which poses a high risk of developing isolates with acquired resistance and recurrent infections.”
Fongémies : épidémiologie, diagnostic et conduite à tenir
Dellière, S., Chantelot, L., Garnaud, C., & Cornet, M. (2026) · EMC - Biologie Médicale · doi:10.1016/s2211-9698(25)48322-8
Metadata
- Authors
- Cleveland, A. A., Farley, M. M., Harrison, L. H., Stein, B., Hollick, R., Lockhart, S. R., Magill, S. S., Derado, G., Park, B. J., & Chiller, T. M.
- Affiliations
- Centers for Disease Control and Prevention (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-14
- Volume
- 55
- Issue
- 10
- Pages
- 1352-1361
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2157512355
- Cited by
- 366
- References
- 138
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 17 · 2023: 16 · 2022: 23 · 2021: 32 · 2020: 35 · 2019: 21 · 2018: 42 · 2017: 35 · 2016: 28 · 2015: 44 · 2014: 33 · 2013: 19 · 2012: 2
- FWCI
- 21.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CC999999)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, candidemia incidence, antifungal resistance, fluconazole resistance, echinocandin resistance, Candida glabrata, multidrug resistance, infants, older adults, epidemiological trends, antifungal prophylaxis, infection control, catheter-related infection, Atlanta, Baltimore
- MeSH terms
- Adolescent, Adult, Aged, Antifungal Agents, Candida, Child, Child, Preschool, Female, Georgia, Humans, Infant, Male, Middle Aged, Population Surveillance, Prospective Studies, Baltimore, Incidence, Drug Resistance, Fungal, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.